Ubisoft unveils The Division Resurgence for iOS and Android

Massive Entertainment's popular RPG shooter, The Division, is leaping over to a new platform soon: mobile. Titled The Division Resurgence, Ubisoft today announced the game as a free-to-play entry that's coming to Android and iOS. Watch the in-engine trailer above.

Like in the main series, players are back to being an agent of the Strategic Homeland Division, but this time, their role will be in the first wave sent to New York City following the virus outbreak. According to Ubisoft, this will be an AAA experience featuring a fresh storyline that's cannon with the overarching plot of the main series.

While deeper details about the game will come later, it was revealed today that there will be a full open world to explore both solo and in co-op while completing various PvE activities. The series' character skill specializations, looting, crafting, and other gameplay systems are making a return too. Being a free-to-play game, this area may be where the main monetization systems come into play.

The Division Resurgence in-game screenshot

"Our objective in bringing The Division universe to mobile, is to enable more people worldwide to enjoy this open world experience whenever and wherever they want," says Ubisoft regarding the targeted platforms. "We feel very lucky that the mobile market has evolved to the point where we can develop such an ambitious game."

Ubisoft has not yet provided a release window for The Division Resurgence, but a closed alpha session is slated to kick off soon across Android and iOS. Head here for instructions on how to get an invite.

Report a problem with article
The Apple logo on a black background surrounded by grey and red rings
Next Article

Apple's upcoming operating systems will feature ultra-secure Lockdown Mode

BBC Sounds Android app open in Windows 11
Previous Article

Windows Subsystem for Android July update adds AV1 support, updated Settings, and more

Join the conversation!

Login or Sign Up to read and post a comment.

7 Comments - Add comment